Hepatocellular injury, characterized by elevated AST and/or ALT, is one of the more common patterns observed in IBD patients, and it may result from the inflammatory process itself, metabolic dysfunction, or adverse effects of pharmacological treatment [76,77]. The gene discussed is GPT; the disease is inflammatory bowel disease.